UniProt ID | FINC_MOUSE | |
---|---|---|
UniProt AC | P11276 | |
Protein Name | Fibronectin | |
Gene Name | Fn1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 2477 | |
Subcellular Localization | Secreted, extracellular space, extracellular matrix. | |
Protein Description | Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin. Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape healing, and maintenance of cell shape. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization. Participates in the regulation of type I collagen deposition by osteoblasts.; Anastellin binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling (By similarity).. | |
Protein Sequence | MLRGPGPGRLLLLAVLCLGTSVRCTEAGKSKRQAQQIVQPQSPVAVSQSKPGCFDNGKHYQINQQWERTYLGNALVCTCYGGSRGFNCESKPEPEETCFDKYTGNTYKVGDTYERPKDSMIWDCTCIGAGRGRISCTIANRCHEGGQSYKIGDKWRRPHETGGYMLECLCLGNGKGEWTCKPIAEKCFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGNGRITCTSRNRCNDQDTRTSYRIGDTWSKKDNRGNLLQCVCTGNGRGEWKCERHALQSASAGSGSFTDVRTAIYQPQTHPQPAPYGHCVTDSGVVYSVGMQWLKSQGNKQMLCTCLGNGVSCQETAVTQTYGGNSNGEPCVLPFTYNGRTFYSCTTEGRQDGHLWCSTTSNYEQDQKYSFCTDHAVLVQTRGGNSNGALCHFPFLYNNRNYTDCTSEGRRDNMKWCGTTQNYDADQKFGFCPMAAHEEICTTNEGVMYRIGDQWDKQHDLGHMMRCTCVGNGRGEWACIPYSQLRDQCIVDDITYNVNDTFHKRHEEGHMLNCTCFGQGRGRWKCDPIDQCQDSETRTFYQIGDSWEKFVHGVRYQCYCYGRGIGEWHCQPLQTYPGTTGPVQVIITETPSQPNSHPIQWNAPEPSHITKYILRWRPKTSTGRWKEATIPGHLNSYTIKGLTPGVIYEGQLISIQQYGHREVTRFDFTTSASTPVTSNTVTGETAPYSPVVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNVYQISEEGKQSLILSTSQTTAPDAPPDPTVDQVDDTSIVVRWSRPQAPITGYRIVYSPSVEGSSTELNLPETANSVTLSDLQPGVQYNITIYAVEENQESTPVFIQQETTGTPRSDNVPPPTDLQFVELTDVKVTIMWTPPDSVVSGYRVEVLPVSLPGEHGQRLPVNRNTFAEITGLSPGVTYLFKVFAVHQGRESNPLTAQQTTKLDAPTNLQFVNETDRTVLVTWTPPRARIAGYRLTAGLTRGGQPKQYNVGPLASKYPLRNLQPGSEYTVTLVAVKGNQQSPKATGVFTTLQPLRSIPPYNTEVTETTIVITWTPAPRIGFKLGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYTYTIQVLRDGQERDAPIVNRVVTPLSPPTNLHLEANPDTGVLTVSWERSTTPDITGYRITTTPTNGQQGTSLEEVVHADQSSCTFENLNPGLEYNVSVYTVKDDKESAPISDTVVPEVPQLTDLSFVDITDSSIGLRWTPLNSSTIIGYRITVVAAGEGIPIFEDFVDSSVGYYTVTGLEPGIDYDISVITLINGGESAPTTLTQQTAVPPPTDLRFTNIGPDTMRVTWAPPPSIELTNLLVRYSPVKNEEDVAELSISPSDNAVVLTNLLPGTEYLVSVSSVYEQHESIPLRGRQKTGLDSPTGFDSSDITANSFTVHWVAPRAPITGYIIRHHAEHSVGRPRQDRVPPSRNSITLTNLNPGTEYVVSIIAVNGREESPPLIGQQATVSDIPRDLEVIASTPTSLLISWEPPAVSVRYYRITYGETGGNSPVQEFTVPGSKSTATINNIKPGADYTITLYAVTGRGDSPASSKPVSINYKTEIDKPSQMQVTDVQDNSISVRWLPSTSPVTGYRVTTTPKNGLGPSKTKTASPDQTEMTIEGLQPTVEYVVSVYAQNRNGESQPLVQTAVTNIDRPKGLAFTDVDVDSIKIAWESPQGQVSRYRVTYSSPEDGIRELFPAPDGEDDTAELQGLRPGSEYTVSVVALHDDMESQPLIGIQSTAIPAPTNLKFSQVTPTSFTAQWIAPSVQLTGYRVRVNPKEKTGPMKEINLSPDSSSVIVSGLMVATKYEVSVYALKDTLTSRPAQGVITTLENVSPPRRARVTDATETTITISWRTKTETITGFQVDAIPANGQTPVQRSISPDVRSYTITGLQPGTDYKIHLYTLNDNARSSPVIIDASTAIDAPSNLRFLTTTPNSLLVSWQAPRARITGYIIKYEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQKSEPLIGRKKTDELPQLVTLPHPNLHGPEILDVPSTVQKTPFITNPGYDTENGIQLPGTTHQQPSVGQQMIFEEHGFRRTTPPTAATPVRLRPRPYLPNVDEEVQIGHVPRGDVDYHLYPHVPGLNPNASTGQEALSQTTISWTPFQESSEYIISCQPVGTDEEPLQFQVPGTSTSATLTGLTRGVTYNIIVEALQNQRRHKVREEVVTVGNAVSEGLNQPTDDSCFDPYTVSHYAIGEEWERLSDAGFKLTCQCLGFGSGHFRCDSSKWCHDNGVNYKIGEKWDRQGENGQRMSCTCLGNGKGEFKCDPHEATCYDDGKTYHVGEQWQKEYLGAICSCTCFGGQRGWRCDNCRRPGAAEPSPDGTTGHTYNQYTQRYNQRTNTNVNCPIECFMPLDVQADRDDSRE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
33 | Pyrrolidone_carboxylic_acid | EAGKSKRQAQQIVQP HHCCCHHHHHHHCCC | 47.46 | - | |
33 | Pyrrolidone_carboxylic_acid | EAGKSKRQAQQIVQP HHCCCHHHHHHHCCC | 47.46 | - | |
42 | Phosphorylation | QQIVQPQSPVAVSQS HHHCCCCCCCEECCC | 28.20 | 28066266 | |
47 | Phosphorylation | PQSPVAVSQSKPGCF CCCCCEECCCCCCCC | 20.99 | 28066266 | |
49 | Phosphorylation | SPVAVSQSKPGCFDN CCCEECCCCCCCCCC | 33.06 | 28066266 | |
91 | Acetylation | RGFNCESKPEPEETC CCCCCCCCCCCCCCC | 30.98 | 22826441 | |
108 | Acetylation | KYTGNTYKVGDTYER CCCCCEEEECCCCCC | 37.39 | 7923473 | |
181 | Acetylation | GKGEWTCKPIAEKCF CCCEEEEHHHHHHHH | 31.89 | 22826441 | |
280 | Phosphorylation | RHALQSASAGSGSFT EEECCCCCCCCCCCC | 38.11 | 24719451 | |
283 | Phosphorylation | LQSASAGSGSFTDVR CCCCCCCCCCCCCHH | 30.86 | 26824392 | |
285 | Phosphorylation | SASAGSGSFTDVRTA CCCCCCCCCCCHHHE | 27.03 | 26824392 | |
287 | Phosphorylation | SAGSGSFTDVRTAIY CCCCCCCCCHHHEEC | 34.97 | 19060867 | |
291 | Phosphorylation | GSFTDVRTAIYQPQT CCCCCHHHEECCCCC | 19.77 | 25293948 | |
294 | Phosphorylation | TDVRTAIYQPQTHPQ CCHHHEECCCCCCCC | 16.21 | 25293948 | |
298 | Phosphorylation | TAIYQPQTHPQPAPY HEECCCCCCCCCCCC | 42.05 | 25293948 | |
305 | Phosphorylation | THPQPAPYGHCVTDS CCCCCCCCCEEECCC | 22.93 | 25293948 | |
310 | Phosphorylation | APYGHCVTDSGVVYS CCCCEEECCCCCEEE | 29.82 | 25293948 | |
312 | Phosphorylation | YGHCVTDSGVVYSVG CCEEECCCCCEEEEC | 24.91 | 25293948 | |
316 | Phosphorylation | VTDSGVVYSVGMQWL ECCCCCEEEECHHHH | 8.67 | 25293948 | |
317 | Phosphorylation | TDSGVVYSVGMQWLK CCCCCEEEECHHHHH | 10.69 | 25293948 | |
372 | Phosphorylation | TYNGRTFYSCTTEGR EECCEEEEEEECCCC | 11.39 | - | |
374 | Glutathionylation | NGRTFYSCTTEGRQD CCEEEEEEECCCCCC | 3.58 | 24333276 | |
430 | N-linked_Glycosylation | PFLYNNRNYTDCTSE EEEECCCCCCCCCCC | 46.29 | - | |
432 | O-linked_Glycosylation | LYNNRNYTDCTSEGR EECCCCCCCCCCCCC | 28.31 | 30059200 | |
444 | Acetylation | EGRRDNMKWCGTTQN CCCCCCCCCCCCCCC | 45.66 | 22826441 | |
486 | Acetylation | RIGDQWDKQHDLGHM EECCCCHHHCCCCCC | 46.72 | 22826441 | |
528 | N-linked_Glycosylation | DDITYNVNDTFHKRH EEEEEECCCHHHHHC | 38.68 | 19656770 | |
542 | N-linked_Glycosylation | HEEGHMLNCTCFGQG CCCCCEEEEEEECCC | 16.10 | - | |
554 | Acetylation | GQGRGRWKCDPIDQC CCCCCCEEECCCHHC | 27.65 | 22826441 | |
575 | Phosphorylation | TFYQIGDSWEKFVHG EEEEECCHHHHHHCC | 31.74 | 25338131 | |
655 | Acetylation | KTSTGRWKEATIPGH CCCCCCCEEEECCCC | 35.79 | 22826441 | |
756 | Phosphorylation | FRVEYELSEEGDEPQ EEEEEEECCCCCCCC | 22.97 | 20531401 | |
764 | Phosphorylation | EEGDEPQYLDLPSTA CCCCCCCCCCCCCCC | 16.95 | 20531401 | |
769 | Phosphorylation | PQYLDLPSTATSVNI CCCCCCCCCCCCCCC | 37.66 | 20531401 | |
770 | Phosphorylation | QYLDLPSTATSVNIP CCCCCCCCCCCCCCC | 31.82 | 20531401 | |
772 | Phosphorylation | LDLPSTATSVNIPDL CCCCCCCCCCCCCHH | 33.04 | 20531401 | |
773 | Phosphorylation | DLPSTATSVNIPDLL CCCCCCCCCCCCHHC | 15.65 | 20531401 | |
875 | Sulfation | DLQPGVQYNITIYAV HCCCCCEEEEEEEEE | 13.21 | - | |
875 | Sulfation | DLQPGVQYNITIYAV HCCCCCEEEEEEEEE | 13.21 | - | |
876 | N-linked_Glycosylation | LQPGVQYNITIYAVE CCCCCEEEEEEEEEE | 14.08 | - | |
880 | Sulfation | VQYNITIYAVEENQE CEEEEEEEEEECCCC | 8.92 | - | |
880 | Sulfation | VQYNITIYAVEENQE CEEEEEEEEEECCCC | 8.92 | - | |
931 | Phosphorylation | IMWTPPDSVVSGYRV EEECCCCCCCCCEEE | 30.14 | - | |
934 | Phosphorylation | TPPDSVVSGYRVEVL CCCCCCCCCEEEEEE | 28.14 | - | |
936 | Phosphorylation | PDSVVSGYRVEVLPV CCCCCCCEEEEEEEC | 12.18 | - | |
975 | Acetylation | PGVTYLFKVFAVHQG CCCEEEEEEEEEECC | 33.57 | 156361 | |
1001 | N-linked_Glycosylation | TKLDAPTNLQFVNET CCCCCCCCCEEECCC | 30.68 | 19656770 | |
1006 | N-linked_Glycosylation | PTNLQFVNETDRTVL CCCCEEECCCCCEEE | 47.98 | 16944957 | |
1008 | O-linked_Glycosylation | NLQFVNETDRTVLVT CCEEECCCCCEEEEE | 26.10 | 30059200 | |
1049 | Acetylation | NVGPLASKYPLRNLQ ECCCCCCCCCCCCCC | 45.33 | 22826441 | |
1074 | Phosphorylation | AVKGNQQSPKATGVF EEECCCCCCCCCCEE | 20.71 | 24719451 | |
1076 | Ubiquitination | KGNQQSPKATGVFTT ECCCCCCCCCCEEEE | 64.92 | 22790023 | |
1076 | Ubiquitination | KGNQQSPKATGVFTT ECCCCCCCCCCEEEE | 64.92 | 22790023 | |
1082 | Phosphorylation | PKATGVFTTLQPLRS CCCCCEEEECEECCC | 24.96 | - | |
1243 | N-linked_Glycosylation | LNPGLEYNVSVYTVK CCCCCEEEEEEEEEE | 15.37 | - | |
1290 | N-linked_Glycosylation | GLRWTPLNSSTIIGY EEEEEECCCCCEEEE | 34.81 | 19656770 | |
1376 | Phosphorylation | GPDTMRVTWAPPPSI CCCCEEEEECCCCCE | 12.92 | 23984901 | |
1382 | Phosphorylation | VTWAPPPSIELTNLL EEECCCCCEEEEEEE | 34.17 | 23984901 | |
1527 | Phosphorylation | AVNGREESPPLIGQQ EECCCCCCCCCCCCC | 27.37 | 28285833 | |
1622 | Acetylation | GDSPASSKPVSINYK CCCCCCCCCEEEEEE | 47.12 | 22826441 | |
1634 | Acetylation | NYKTEIDKPSQMQVT EEECCCCCCCCCEEE | 52.83 | 23806337 | |
1757 | Phosphorylation | SRYRVTYSSPEDGIR EEEEEEECCCCCCHH | 30.01 | 23984901 | |
1758 | Phosphorylation | RYRVTYSSPEDGIRE EEEEEECCCCCCHHH | 23.15 | 23984901 | |
1861 | Phosphorylation | PMKEINLSPDSSSVI CCCEEECCCCCCCEE | 23.36 | 25777480 | |
1864 | Phosphorylation | EINLSPDSSSVIVSG EEECCCCCCCEEEEC | 28.09 | 25777480 | |
1865 | Phosphorylation | INLSPDSSSVIVSGL EECCCCCCCEEEECC | 35.68 | 25777480 | |
1866 | Phosphorylation | NLSPDSSSVIVSGLM ECCCCCCCEEEECCE | 21.58 | 25777480 | |
1870 | Phosphorylation | DSSSVIVSGLMVATK CCCCEEEECCEEEEE | 18.32 | 25777480 | |
1970 | Acetylation | LQPGTDYKIHLYTLN CCCCCEEEEEEEECC | 26.85 | 15605879 | |
2003 | Phosphorylation | PSNLRFLTTTPNSLL CCCCEEEECCCCCEE | 26.38 | 25890499 | |
2008 | Phosphorylation | FLTTTPNSLLVSWQA EEECCCCCEEEEEEC | 25.04 | 25890499 | |
2026 | Acetylation | RITGYIIKYEKPGSP EEEEEEEEECCCCCC | 37.49 | 22826441 | |
2029 | Acetylation | GYIIKYEKPGSPPRE EEEEEECCCCCCCCC | 52.14 | 23806337 | |
2071 | Acetylation | IALKNNQKSEPLIGR EEEECCCCCCCCCCC | 59.93 | 22826441 | |
2198 | N-linked_Glycosylation | HVPGLNPNASTGQEA CCCCCCCCCCCCHHH | 45.51 | 19656770 | |
2330 | Phosphorylation | CQCLGFGSGHFRCDS EEECCCCCCEEEECC | 27.17 | 21183079 | |
2337 | Phosphorylation | SGHFRCDSSKWCHDN CCEEEECCCCCCCCC | 37.13 | 30635358 | |
2338 | Phosphorylation | GHFRCDSSKWCHDNG CEEEECCCCCCCCCC | 19.54 | 30635358 | |
2392 | Sulfation | CYDDGKTYHVGEQWQ EECCCCEEEECHHHH | 9.67 | - | |
2392 | Sulfation | CYDDGKTYHVGEQWQ EECCCCEEEECHHHH | 9.67 | - | |
2432 | Phosphorylation | RPGAAEPSPDGTTGH CCCCCCCCCCCCCCC | 27.42 | 24719451 | |
2452 | Phosphorylation | TQRYNQRTNTNVNCP HHHHHCCCCCCCCCC | 36.31 | 25619855 | |
2454 | Phosphorylation | RYNQRTNTNVNCPIE HHHCCCCCCCCCCEE | 39.67 | 25619855 | |
2464 | Oxidation | NCPIECFMPLDVQAD CCCEEEEEECCEECC | 4.94 | 17242355 | |
2475 | Phosphorylation | VQADRDDSRE----- EECCCCCCCC----- | 42.47 | 25521595 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FINC_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FINC_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FINC_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of FINC_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1006 AND ASN-1290, ANDMASS SPECTROMETRY. | |
"The mouse C2C12 myoblast cell surface N-linked glycoproteome:identification, glycosite occupancy, and membrane orientation."; Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I.,Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E.,Wollscheid B.; Mol. Cell. Proteomics 8:2555-2569(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-528; ASN-1001; ASN-1006;ASN-1290 AND ASN-2198, AND MASS SPECTROMETRY. | |
"Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides."; Bernhard O.K., Kapp E.A., Simpson R.J.; J. Proteome Res. 6:987-995(2007). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-528, AND MASSSPECTROMETRY. | |
"Proteome-wide characterization of N-glycosylation events by diagonalchromatography."; Ghesquiere B., Van Damme J., Martens L., Vandekerckhove J.,Gevaert K.; J. Proteome Res. 5:2438-2447(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1006, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2475, AND MASSSPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2475, AND MASSSPECTROMETRY. | |
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis."; Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; J. Proteome Res. 7:3957-3967(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2475, AND MASSSPECTROMETRY. |